Market Index8h
Morning Wrap: ASX 200 to tumble, S&P 500 and Nasdaq record worst session since 2020
US markets closed sharply lower, with the S&P 500 and Nasdaq recording their worst sessions since March 2020 Russell 2000 ...
US tech, retail stocks lead rout after Trump’s tariff blow
(Reuters) -Megacap U.S. tech companies including Apple (NASDAQ: AAPL) and retail giants Walmart (NYSE: WMT) and Nike (NYSE: ...
Update On Oil Services And The OIH ETF Product (Rating Upgrade)
Explore the impact of falling crude oil prices & energy policies on oil services. Click for my updated look at VanEck Oil ...
DXUV: Questionable Quality For Dimensional's Value-Leaning Broad Market ETF
Dimensional US Vector Equity ETF provides value with earnings growth. Read why DXUV's higher volatility and quality concerns ...
UK Publishes List of Goods for Potential US Tariff Response
The so-called indicative list of products encompasses around 27% of British imports of U.S.-origin goods, based on 2024 data, ...
CEX listings outperform Nasdaq and Dow IPOs with 80% average returns
Crypto exchange token listings have yielded an 80% average ROI, outperforming traditional stocks, per CoinMarketCap. Binance defends listing criteria.
Jyong Biotech Ltd. (Revived IPO) (MENS) to Raise $22 Million in IPO
Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an initial public offering (IPO) on the week of April 7th, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.
Jyong Biotech Ltd. (Revived IPO) (MENS) Announces April 7th IPO
Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on the week of April 7th, IPO Scoop reports.